- June 14, 2013
- Nippon Shinyaku receives marketing authorization of “Tramal® Capsule 25mg” and “Tramal® Capsule 50mg” in Japan for the treatment of chronic pain as an indication extension
- May 27, 2013
- Launch of Regtect® Tablets 333mg, the first approved drug in Japan for support maintenance of abstinence in patients with alcohol dependence
